Cite

HARVARD Citation

    Gibb, M. et al. (n.d.). An audit of toxicity from first-line immunotherapy in inoperable or metastatic non-small cell lung cancer patients divided by ECOG performance status. Lung cancer. pp. S56-. [Online]. 
  
Back to record